Synthesis and Evaluation of Novel (5S)-5-(Aminomethyl)-3-[4-(6,7-Dihydrothieno[3,2-c]Pyridin-5(4H)-yl)Phenyl]-1,3-Oxazolidin-2-One Derivatives as Potent Antimicrobial Agents

References

• Amyes Sgb, and C.G. Gemmell, “Antibiotic Resistance,” Journal of Medical Microbiology 46 (1997): 436–70.
   Web of Science ®Google Scholar
• R. Sood, T. Bhadauriya, M. Rao, R. Gautam, S. Malhotra, T.K. Barman, D.J. Upadhyay, and A. Rattan, “Antimycobacterial Activities of Oxazolidinones: A Review,” Infectious Disorders Drug Targets 6, no. 4 (2006): 343–54.
   PubMedGoogle Scholar
• B. Bulent, and C.A. Peter, “Oxazolidinones: Activity, Mode of Action, and Mechanism of Resistance,” International Journal of Antimicrobial Agents 23, no. 2 (2004): 113–9.
   PubMed Web of Science ®Google Scholar
• U. Patel, Y.P. Yan, F.W. Hobbs, J.J. Kaczmarczyk, A.M. Slee, D.L. Pompliano, M.G. Kurilla, and E.V. Bobkova, “Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond Formation,” The Journal of Biological Chemistry 276, no. 40 (2001): 37199–205.
   PubMed Web of Science ®Google Scholar
• M. Yousefi, and M. Ghashang, “SiO2‐POCl2 Nanoparticles Promoted the Synthesis of Novel Structure of 2,3‐Dihydrooxazole Derivatives,” Journal of Heterocyclic Chemistry 56, no. 11 (2019): 3152–6.
   Web of Science ®Google Scholar
• Mehdi Abaszadeh, Seyyed Jalal Roudbaraki, Hossein Yarahmadi, and Majid Ghashang, “SiO2-POCl2 Nano-Particles Promoted the Synthesis of Novel Structure of Alkyl 2-Oxo-3,4-Diaryloxazolidine-5-Carboxylate Derivatives,” Letters in Organic Chemistry 18, no. 2 (2021): 88–94.
   Web of Science ®Google Scholar
• D.L. Stevens, B. Dotter, and K. Madaras-Kelly, “A Review of Linezolid: The First Oxazolidinone Antibiotic,” Expert Review of anti-Infective Therapy 2, no. 1 (2004): 51–9.
   PubMedGoogle Scholar
• D. Andes, M.L. Van Ogtrop, J. Peng, and W.A. Craig, “In Vivo Pharmacodynamics of a New Oxazolidinone (Linezolid),” Antimicrobial Agents and Chemotherapy 46, no. 11 (2002): 3484–9.
   PubMed Web of Science ®Google Scholar
• A.J. Lepak, K. Marchillo, S. Pichereau, W.A. Craig, and D.R. Andes, “Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model,” Antimicrobial Agents and Chemotherapy 56, no. 11 (2012): 5916–22.
   PubMed Web of Science ®Google Scholar
• R. Lowes, New Antibiotic Tedizolid (Sivextro) Approved by FDA. 2014. http://www.medscape.com/viewarticle/827168
   Google Scholar
• Ahmet Özdemir, Gülhan Turan-Zitouni, Zafer Asım Kaplancıklı, Gökalp İşcan, Shabana Khan, and Fatih Demirci, “Synthesis and the Selective Antifungal Activity of 5,6,7,8-Tetrashydroimidazo[1,2-a]Pyridine Derivatives,” European Journal of Medicinal Chemistry 45, no. 5 (2010): 2080–4.
   PubMed Web of Science ®Google Scholar
• T. Suksrichavalit, S. Prachayasittikul, C. Nantasenamat, C. Isarankura-Na-Ayudhya, and V. Prachayasittikul, “Copper Complexes of Pyridine Derivatives with Superoxide Scavenging and Antimicrobial Activities,” European Journal of Medicinal Chemistry 44, no. 8 (2009): 3259–65.
   PubMed Web of Science ®Google Scholar
• P. Thirumurugan, S. Mahalaxmi, and P. Perumal, “Synthesis and Anti-Inflammatory Activity of 3-Indolyl Pyridine Derivatives through Multi Component Reaction,” Journal of Chemical Sciences 122, no. 6 (2010): 819–32.
   Web of Science ®Google Scholar
• Akbar Idhayadhul, Radhakrishnan Surend Kumar, Abdul Jamal Abdul Nasser, and Aseer Manilal, “Synthesis of Some New Pyrrole and Pyridine Derivatives and Their Antimicrobial, Anticancer Activities,” International Journal of Biological Chemistry 7, no. 1 (2012): 15–26.
   Google Scholar
• D.J. Angiolillo, E.R. Bates, and T.A. Bass, “Clinical Profile of Prasugrel, a Novel Thienopyridine,” American Heart Journal 156, no. 2 (2008): 16S–22S.
   Web of Science ®Google Scholar
• D. Alexopoulos, “P2Y12 Receptor Inhibitors in Acute Coronary Syndromes: From the Research Laboratory to the Clinic and Vice Versa,” Cardiology 127, no. 4 (2014): 211–9219.
   PubMed Web of Science ®Google Scholar
• Alice Maria Rolim Bernardino, Luiz Carlos da Silva Pinheiro, Carlos Rangel Rodrigues, Natália Izabel Loureiro, Helena Carla Castro, Adriana Lanfredi-Rangel, Juliano Sabatini-Lopes, Júlio César Borges, Jane Maria Carvalho, Gilberto Alves Romeiro, et al., “Design, Synthesis, SAR, and Biological Evaluation of New 4-(Phenylamino)Thieno[2, 3-b]Pyridine Derivatives,” Bioorganic & Medicinal Chemistry 14, no. 16 (2006): 5765–70. :
   PubMed Web of Science ®Google Scholar
• X. Zeng, R. Zheng, T. Zhou, H. He, J. Liu, Y. Zheng, A. Tong, M. Xiang, X. Song, S. Yang, et al., “Novel Thienopyridine Derivatives as Specific Anti-Heptacellular Carcinoma (HCC) Agents: Synthesis, Preliminary Structure-Activity Relationships, and In Vitro Biological Evaluation,” Bioorganic & Medicinal Chemistry Letters 20, no. 21 (2010): 6282–5.
   PubMed Web of Science ®Google Scholar
• B.K. Srivastava, M. Solanki, B. Mishra, R. Soni, S. Jayadev, D. Valani, M. Jain, and P.R. Patel, “Synthesis and Antibacterial Activity of 4,5,6,7-Tetrahydro-Thieno[3,2-c]Pyridine Quinolones,” Bioorganic and Medicinal Chemistry Letters 17, no. 7 (2007): 1924–9.
   PubMed Web of Science ®Google Scholar
• J.N. Sangshetti, F.A. Kalam Khan, R.S. Chouthe, M.G. Damale, and D.B. Shinde, “Synthesis, Docking and ADMET Prediction of Novel 5-((5-Substituted-1-H-1,2,4-Triazol-3-yl)Methyl)-4,5,6,7-Tetrahydrothieno[3,2-c]Pyridine as Antifungal Agents,” Chinese Chemical Letters 25, no. 7 (2014): 1033–8.
   Web of Science ®Google Scholar
• K. Madhusudana, B. Shireesha, V.G.M. Naidu, S. Ramakrishna, B. Narsaiah, A.R. Rao, and P.V. Diwan, “Anti-Inflammatory Potential of Thienopyridines as Possible Alternative to NSAIDs,” European Journal of Pharmacology 678, no. 1–3 (2012): 48–54.
   PubMed Web of Science ®Google Scholar
• F.A. Attaby, M.A.A. Elneairy, and M.S. Elsayed, “Synthesis and Antimicrobial Evaluation of New Pyridine, Thienopyridine and Pyridothienopyrazole Derivatives,” Archives of Pharmacal Research 22, no. 2 (1999): 194–201.
   PubMed Web of Science ®Google Scholar
• A.E. Ghattas, A. Khodairy, H.M. Moustafa, and B.R.M. Hussein, “Synthesis and Biological Evaluation of Some Novel Thienopyridines,” Journal of Pharmaceutical and Applied Chemistry 1, no. 1 (2015): 21–6.
   Google Scholar
• E.A. Bakhite, A.E. Abdel-Rahman, O.S. Mohamed, and E.A. Thabet, “Synthesis and Reactions of New Thienopyridines, Pyridothienopyrimidines and Pyridothienotriazines,” Bulletin of the Korean Chemical Society 23, no. 12 (2002): 1709.
   Web of Science ®Google Scholar
• V.P. Modi, P.N. Patel, and H.S. Patel, “Synthesis, Spectral Investigation and Biological Evaluation of Novel Non-Cytotoxic Tetrahydrothieno[3, 2-c]Pyridine Hydrazide Derivatives,” Der Pharmacia Lettre 3, no. 4 (2011): 120–33.
   Google Scholar
• Gary L. Grunewald, Mitchell R. Seim, Seema R. Bhat, Marc E. Wilson, and Kevin R. Criscione, “Synthesis of 4,5,6,7-Tetrahydrothieno[3,2-c]Pyridines and Comparison with Their Isosteric 1,2,3,4-Tetrahydroisoquinolines as Inhibitors of Phenylethanolamine N-Methyltransferase,” Bioorganic & Medicinal Chemistry 16, no. 1 (2008): 542–59.
   PubMed Web of Science ®Google Scholar
• A. Katritzky, Advances in Heterocyclic Chemistry, Vol. 93, 1st ed. (Amsterdam: Elsevier, 2007).
   Google Scholar
• N. Pandit, R.K. Singla, and B. Shrivastava, “Current Updates on Oxazolidinone and Its Significance,” International Journal of Medicinal Chemistry 2012 (2012): 159285.
   PubMedGoogle Scholar
• Nilesh S. Patil, Ganesh B. Deshmukh, Sambhaji V. Patil, Avinash D. Bholay, and Nitin D. Gaikwad, “Synthesis and Biological Evaluation of Novel N-Aryl Maleimide Derivatives Clubbed with α-Hydroxyphosphates,” European Journal of Medicinal Chemistry 83, no. 83 (2014): 490–7.
   PubMedGoogle Scholar